About
Contact & Profiles
A5015178884
Research Areas
- Botulinum Toxin and Related Neurological Disorders
- Myofascial pain diagnosis and treatment
- Stroke Rehabilitation and Recovery
- Cerebral Palsy and Movement Disorders
- Acupuncture Treatment Research Studies
- Musicians’ Health and Performance
A clinical case of consistent use botulinum toxin type (BTA) and azoximer bovhialuronidase (BA) in a 69-year-old patient who suffered an ischemic stroke (II) with right-sided hemiparesis is presented. BTA (incobotulotoxin) was injected under ultrasound control (ultrasound) into the muscles target pathological patterns at dose 500 units. After 3 weeks, navigation, BA 2 most fibrotic shoulder 3.000 IU (1.500 each). The effectiveness therapy monitored using modified Ashworth scale (MAS),...
10.17116/jnevro202512502180
article
EN
S S Korsakov Journal of Neurology and Psychiatry
2025-03-06
10.1016/j.toxicon.2021.11.076
article
EN
Toxicon
2022-07-01
10.1016/j.toxicon.2021.11.075
article
EN
Toxicon
2022-07-01
Coming Soon ...